Are G Protein‐Coupled Receptor Heterodimers of Physiological Relevance?—Focus on Melatonin Receptors

Abstract

In mammals, the circadian hormone melatonin targets two seven‐transmembrane–spanning receptors, MT₁ and MT₂, of the G protein‐coupled receptor (GPCR) super‐family. Evidence accumulated over the last 15 yrs convincingly demonstrates that GPCRs, classically considered to function as monomers, are actually organized as homodimers and heterodimerize with other GPCR family members. These dimers are formed early in the biosynthetic pathway and remain stable throughout the entire life cycle. A growing number of observations demonstrate that GPCR oligomerization may occur in native tissues and may have important consequences on receptor function. The formation of MT₁ and MT₂ homodimers and MT₁/MT₂ heterodimers has been shown in heterologous expression systems at physiological expression levels. Formation of MT₁/MT₂ heterodimers remains to be shown in native tissues but is suggested by the documented co‐expression of MT₁ and MT₂ in many melatonin‐sensitive tissues, such as the hypothalamic suprachiasmatic nuclei, retina, arteries, and adipose tissue. Considering that multiple GPCRs are expressed simultaneously in most cells, the possible engagement into heterodimeric complexes has to be considered and taken into account for the interpretation of experimental data obtained from native tissues and knockout animals.

• Melatonin
• Circadian rhythm
• G protein‐coupled receptors